Alafair Biosciences Inc said Aug 9 that it completed a $2 million Series A round led by ATP Fund. Existing and new investors took part including the UT Horizon Fund. Austin-based Alafair is a medical device company that is developing surgical products for soft tissue repair and protection applications.
Source: BusinessWire
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.